EUVIMEDEUVIMED entdecken
Crossref

Safety and Biodistribution of Nanoligomers Targeting the SARS-CoV-2 Genome for the Treatment of COVID-19

Colleen R McCollum, Colleen M Courtney, Nolan J O'Connor, Thomas R Aunins, Tristan X Jordan, Keegan L Rogers, Stephen Brindley, Jared M Brown, Prashant Nagpal iD, Anushree Chatterjee iD

ACS Biomaterials Science & Engineering · 2023

DOI: 10.1021/acsbiomaterials.2c00669 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2023. Verfasst von Colleen R McCollum und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, Colorado 80303, United States. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, COVID-19 Drug Treatment, Nanostructures. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: NIEHS NIH HHS, U.S. Department of Education, National Aeronautics and Space Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19COVID-19 Drug TreatmentNanostructuresNanomedicinePeptide Nucleic AcidsOligoribonucleotidesGenome, ViralPatient SafetyAnimalsMiceMice, Inbred BALB CIn Vitro TechniquesTissue Distribution

Stichwörter der Autor:innen

COVID-19RNA-dependent RNA polymeraseantisense therapybiodistributionsafety

Substanzen

Peptide Nucleic AcidsSBCoV202Oligoribonucleotides

Autor:innen und Institutionen

  • Department of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, Colorado 80303, United States.
  • Sachi Bio, Colorado Technology Center, Louisville, Colorado 80027, United States.
  • Department of Microbiology, New York University Langone, New York, New York 10016, United States.
  • Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045, United States.
  • Antimicrobial Regeneration Consortium Labs, Louisville, Colorado 80027, United States.

ORCID-Profile: Prashant Nagpal, Anushree Chatterjee

Förderung

  • NIEHS NIH HHS
  • U.S. Department of Education
  • National Aeronautics and Space Administration
  • U.S. Department of Health and Human Services

Zitieren

APA

McCollum, C. R., Courtney, C. M., O'Connor, N. J., Aunins, T. R., Jordan, T. X., Rogers, K. L., Brindley, S., Brown, J. M., Nagpal, P., & Chatterjee, A. (2023). Safety and Biodistribution of Nanoligomers Targeting the SARS-CoV-2 Genome for the Treatment of COVID-19. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.2c00669

Vancouver

McCollum CR, Courtney CM, O'Connor NJ, Aunins TR, Jordan TX, Rogers KL, et al. Safety and Biodistribution of Nanoligomers Targeting the SARS-CoV-2 Genome for the Treatment of COVID-19. ACS Biomaterials Science & Engineering. 2023. doi:10.1021/acsbiomaterials.2c00669

BibTeX
@article{McCollum2023,
  author = {McCollum, Colleen R and Courtney, Colleen M and O'Connor, Nolan J and Aunins, Thomas R and Jordan, Tristan X and Rogers, Keegan L and Brindley, Stephen and Brown, Jared M and Nagpal, Prashant and Chatterjee, Anushree},
  title = {Safety and Biodistribution of Nanoligomers Targeting the SARS-CoV-2 Genome for the Treatment of COVID-19},
  journal = {ACS Biomaterials Science & Engineering},
  year = {2023},
  doi = {10.1021/acsbiomaterials.2c00669}
}
Kostenlos starten →